News reports

National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.

Immunotherapy for triple-negative breast cancer approved for NHS in England 

Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer.

Breast and ovarian cancer drug effective in advanced prostate cancer

A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer.

Non-Hodgkin lymphoma treatment gets an initial ‘no’ for NHS use in England

A new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma has not been recommended for NHS use in England. 

‘Chemotherapy-free’ treatment for lymphoma made available for NHS use in England

New ‘chemotherapy-free’ treatment for follicular lymphoma approved for NHS use in England.

Kidney cancer drug gets initial ‘no’ for the NHS in England

A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England

Pages